Skip to main content
Novartis
language-selector-globe Italia | it
Siti Novartis
  • Americas
  • Asia Pacific
  • Europe
  • International
  • Middle East & Africa
Argentina | Español
Brazil | Português
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Mexico | Español
United States | English
Australia | English
Bangladesh | English
Hong Kong S.A.R. | 繁體中文
India | English
Indonesia | English
Japan | 日本語
Korea | 한국어
Mainland China | 中文
Malaysia | English
Pakistan | English
Philippines | English
Singapore | English
Taiwan | 繁體中文
Thailand | ภาษาไทย
Austria | Deutsch
Belgium | Français
Belgium | Nederlands
Bulgaria | Български
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hungary | Magyar
Ireland | English
Italy | Italiano
Latvia | Latvian
Lithuania | Lithuanian
Netherlands | Nederlands
Norway | Norsk
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Serbia | Srpski
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Türkiye | Türkçe
United Kingdom | English
Global | English
Novartis Foundation | English
Egypt | English
Israel | עברית
Saudi Arabia | العربية
South Africa | English
language-selector-globe Italia
Choose Location
Americas Asia Pacific Europe International Middle East & Africa
Argentina | Español
Australia | English
Austria | Deutsch
Bangladesh | English
Belgium | Français
Belgium | Nederlands
Brazil | Português
Bulgaria | Български
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Egypt | English
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hong Kong S.A.R. | 繁體中文
Hungary | Magyar
India | English
Indonesia | English
Ireland | English
Israel | עברית
Italy | Italiano
Japan | 日本語
Korea | 한국어
Latvia | Latvian
Lithuania | Lithuanian
Mainland China | 中文
Malaysia | English
Mexico | Español
Netherlands | Nederlands
Norway | Norsk
Global | English
Novartis Foundation | English
Pakistan | English
Philippines | English
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Saudi Arabia | العربية
Serbia | Srpski
Singapore | English
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
South Africa | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Taiwan | 繁體中文
Thailand | ภาษาไทย
Türkiye | Türkçe
United Kingdom | English
United States | English
    • Chi siamo 
      • Novartis in Italia 
      • La nostra missione 
      • Aree di attività 
        • Aree terapeutiche 
      • Diversity & Inclusion 
      • La nostra storia 
        • Le nostre origini 
        • Dal 1996 a oggi 
      • Persone 
      viale affollato Chi siamo
    • Per il paziente 
      • Il nostro impegno 
      • Alleati per la Salute 
        • Politiche Sanitarie e Socio Assistenziali 
        • A fianco di chi aiuta 
        • Benessere psicofisico 
        • News dalle Associazioni Pazienti 
        • Mini Lessons EUPATI 
        • Servizi e materiali utili 
        • Novartis Influencer Masterclass for Patients 
        • HTA - Nuovo regolamento 
        • Attualità 
      • Informazione e sensibilizzazione 
        • Campagne di informazione e sensibilizzazione 
      • Linea Embrace per la gestione delle malattie croniche 
      • Segnalazione effetti indesiderati 
      Un medico tiene le mani a un paziente Per il paziente
    • Sostenibilità 
      • Sostenibilità ambientale 
      • Etica e compliance 
      • Diversity & Inclusion 
      • Accesso e diritto alla salute 
      • Salute globale 
      • Reporting 
      • Indici ESG 
      Young patients waiting outside hospital in Rwanda Sostenibilità
    • Ricerca e innovazione 
      • Ricerca & sviluppo 
      • Nuove frontiere della R&S 
      • Novartis, la ricerca clinica in Italia nel 2023 
      • Open Innovation 
      • Professionisti della salute 
      dettaglio di una confezione di pillole Ricerca e innovazione
    • Lavora con noi 
      • Opportunità di lavoro 
      • Come lavoriamo 
      • Benessere 
      • Benefit 
      • Diversity & Inclusion 
      • Riconoscimenti e certificazioni 
      • La nostra cultura 
      Lavora con noi Lavora con noi
    • News 
      • Fatti e notizie 
      • Area riservata ai giornalisti 
      • Comunicati stampa 
      News News
    • Contatti 
    Homepage Italia Home
  1. Home
  2. Lavora con noi
  3. Cerca offerte di lavoro
  • Sort by Sort ascending
  • Titolo di lavoro Sort ascending
  • Site
  • Posizione
  • Divisione
  • Business
  • Area funzionale
  • Data di pubblicazione
Titolo di lavoro Sort ascending Site Posizione Divisione Business Area funzionale Data di pubblicazione
Technical System Lead (Qualification) Sasayama Giappone Operations Innovative Medicines Technical Operations Lug 31, 2024
Technical Services Leader Targu Mures Romania Operations Innovative Medicines Technical Operations Ott 17, 2024
Technical Product Manager: Finance, Cloud Analytics Barcelona Gran Vía Spagna Operations CTS Technology Transformation Ott 09, 2024
Technical Lead Barcelona Gran Vía Spagna Operations CTS Technology Transformation Ott 07, 2024
Tech Transfer Lead Schaftenau Austria Operations Innovative Medicines Technical Operations Set 03, 2024
Team Leader Hyderabad (Office) India Operations CTS Marketing Set 03, 2024
Team Lead Medical Communications (Scientific Engagements) Dublin (Novartis Corporate Center (NOCC)) Irlanda Operations CTS Research & Development Ott 09, 2024
TCM Senior Cash Management Specialist INSURGENTES Messico Operations CTS Audit e finanza Ago 30, 2024
Tax Specialist (m/w/d) Schaftenau Austria Finance CTS Audit e finanza Lug 22, 2024
Tax Manager m/w/d) Nuremberg (Non-Sales Force) (Novartis Pharma GmbH) Germania Finance Corporate Audit e finanza Ott 16, 2024
Talent Acquisition Coordinator INSURGENTES Messico People & Organization CTS Risorse umane Ott 11, 2024
Taktični planer / Tactical planner Ljubljana Slovenia Operations CTS Technical Operations Set 09, 2024
Tactical Planner (f/m/d) Schaftenau Austria Operations Innovative Medicines Technical Operations Set 25, 2024
Tactical planner İstanbul Kurtköy Turchia Operations Innovative Medicines Technical Operations Ago 23, 2024
TA Strategy Lead, RLT (Prostate Cancer) Head Office (Japan) (Pharmaceuticals) Giappone International Innovative Medicines Marketing Ott 07, 2024
TA Strategy Lead - Hematology Head Office (Japan) (Pharmaceuticals) Giappone International Innovative Medicines Marketing Giu 26, 2024
TA Strategy Lead - GenMed Head Office (Japan) (Pharmaceuticals) Giappone International Innovative Medicines Marketing Ott 02, 2024
TA Strategy Director, Immunology East Hanover USA Strategy & Growth Innovative Medicines BD&L & Strategic Planning Giu 11, 2024
T&L Operational Expert Hyderabad (Office) India Operations Innovative Medicines Risorse umane Ott 04, 2024
Supply Chain Graduate Program Associate - UAE National Dubai Emirati Arabi Uniti Operations Innovative Medicines Others Ott 14, 2024
Submission Readiness Document Manager Basel (City) Svizzera Development Innovative Medicines Research & Development Ott 02, 2024
Study Start Up Senior Lead Dublin (Novartis Corporate Center (NOCC)) Irlanda Development Innovative Medicines Research & Development Ott 18, 2024
Study Leader Head Office (Japan) (Pharmaceuticals) Giappone Development Innovative Medicines Research & Development Set 05, 2024
Strategy Manager Taipei Taiwan International Innovative Medicines Marketing Lug 24, 2024
Strategy Director, Clinical Development Basel (City) Svizzera Development Innovative Medicines Research & Development Ott 17, 2024
Strategy and Operations Manager London (The Westworks) Regno Unito Development Innovative Medicines Research & Development Set 13, 2024
Strategic Design Commercial Contracts Manager Barcelona Gran Vía Spagna Operations CTS Marketing Set 24, 2024
SSU Manager INSURGENTES Messico Development Innovative Medicines Research & Development Ott 15, 2024
SSO Study Start-Up Manager London (The Westworks) Regno Unito Development Innovative Medicines Research & Development Ott 16, 2024
SSO Site Partnership Manager Guangzhou (Guangdong Province) Cina Development Innovative Medicines Research & Development Set 17, 2024
SSO Finance Specialist İstanbul Kavacık Turchia Development Innovative Medicines Research & Development Set 10, 2024
Sr.Specialist – Wireless Network Engineering INSURGENTES Messico Operations CTS Technology Transformation Lug 16, 2024
Sr.Spec.DDIT ISC Gov Indep.Control Asses Hyderabad (Office) India Operations CTS Technology Transformation Set 18, 2024
Sr. TA Strategy Lead (Renal Therapy Area) Head Office (Japan) (Pharmaceuticals) Giappone International Innovative Medicines Marketing Ago 07, 2024
Sr. Specialist Qualification Engineer INSURGENTES Messico Operations CTS Technology Transformation Set 11, 2024
Sr. Specialist DDIT ISC Detection & Response Hyderabad (Office) India Operations CTS Technology Transformation Ott 17, 2024
Sr. Specialist DDIT ISC Cyber Solutions Engineering Prague Repubblica Ceca Operations CTS Technology Transformation Ott 09, 2024
Sr. Specialist DDIT ISC CSOC Engineering INSURGENTES Messico Operations CTS Technology Transformation Set 26, 2024
Sr. Specialist DDIT ISC CSOC Engineering Hyderabad (Office) India Operations CTS Technology Transformation Ott 07, 2024
Sr. Specialist DDIT ISC CSOC Engineering Prague Repubblica Ceca Operations CTS Technology Transformation Set 30, 2024
Sr. Specialist DDIT APD ERP PlatformTech Hyderabad (Office) India Operations CTS Technology Transformation Apr 23, 2024
Sr. Specialist (SAP Business Process Automation) Hyderabad (Office) India Operations CTS Technology Transformation Set 13, 2024
Sr. Special. DDIT IES O365 eDLS Ops Hyderabad (Office) India Operations CTS Technology Transformation Mag 29, 2024
Sr. Spec. IT Solution Delivery INSURGENTES Messico Operations CTS Tecnologia dell'informazione Lug 15, 2024
Sr. Spec. DDIT ISC SecOps IAM Hyderabad (Office) India Operations CTS Technology Transformation Apr 17, 2024
Sr. Spec. DDIT ISC SecOps Cyber Tools Hyderabad (Office) India Operations CTS Technology Transformation Mag 07, 2024
Sr. Spec. DDIT ISC QNova Hyderabad (Office) India Operations CTS Technology Transformation Set 24, 2024
Sr. Spec. DDIT ISC IES Hyderabad (Office) India Operations CTS Technology Transformation Mag 21, 2024
Sr. Spec. DDIT ISC Gov SOX IT Method Hyderabad (Office) India Operations CTS Technology Transformation Set 20, 2024
Sr. Spec. DDIT ISC Gov GxP Assessments Hyderabad (Office) India Operations CTS Technology Transformation Ott 18, 2024

Pagination

  • ‹ Previous page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • …
  • 42
  • › Next page

Novartis Farma S.p.A Viale Luigi Sturzo, 43 - 20154 Milano (MI) tel. 02/9654.1
C.F. 07195130153 / P.IVA 02385200122

Novartis Italia

Naviga
  • Per il paziente
  • Professionisti della salute
  • Sostenibilità
  • News
  • Lavora con noi
  • Novartis nel mondo
News
  • Archivio news
  • Fatti & Notizie
  • Comunicati Stampa
  • Area riservata ai giornalisti
Siti web Novartis
  • Sito del gruppo
Footer Bottom
© 2024 Novartis Italia
  • Avvertenze legali
  • Privacy Policy
  • Contatti
  • Impostazioni cookie
  • Mappa del sito
  • Accessibilità
Elenco siti Novartis
Questo sito è destinato a utenti residenti in Italia